Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Clinician's Roundtable

Preventing Bronchoconstriction in Asthma: A Review of the DENALI & MANDALA Trials

ReachMD Healthcare Image
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Comments
  • Overview

    Data from the MANDALA and DENALI clinical trials led to the recent FDA-approval of albuterol/budesonide for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older. Explore the data that led to its approval with this quick recap.

Recommended
Details
Comments
  • Overview

    Data from the MANDALA and DENALI clinical trials led to the recent FDA-approval of albuterol/budesonide for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older. Explore the data that led to its approval with this quick recap.

Schedule12 Oct 2024